08 December 2008

Indian court sets aside Roche’s patent (full version)

Peter Ollier, Hong Kong

The Madras High Court last week set aside a patent granted to Swiss pharmaceutical company F Hoffman La Roche for its blockbuster anti-infection medicine valganciclovir because a pre-grant opposition by two NGOs was not heard.

The decision is another blow to Roche after the company failed to get a preliminary injunction in March against Indian generic drug maker Cipla, which is making its own version of Tarceva, Roche’s lung cancer medication. That case is currently under appeal.

The rest of this article is available to subscribers to Managing IP only.

Managing IP subscribers also have access to Managing Patents, Trade marks and Copyright until 30th October 2010.
Managing IP trialists have access to Managing Patents, Trade marks and Copyright for 48-hours.

Subscribe today for full access to this article. Alternatively, take a 48-hour free trial giving you access to the current content.

If you are already a subscriber please log in (see top right column) to access the rest of this article.

Managing Intellectual Property

Navigation Menu

Managing IP Home Page

Managing IP Products

Browse Magazine

IP Resources

Indian court sets aside Roche’s patent (full version)

The rest of this article is available to subscribers to Managing IP only.

Events